Effectiveness of proprotein convertase subtilisin/kexin-9 monoclonal antibody treatment on plasma lipoprotein(a) concentrations in patients with elevated lipoprotein(a) attending a clinic.

Clin Cardiol · 2021 · PMC8207967 · PMID 33955565

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

Moreover, there was a significant trend to an increase in absolute reductions of plasma Lp(a) levels in patients from the lowest quartile to the highest quartile (i.e., −0.15, −0.23, −0.31, and −0.50 g/L, respectively; ANOVA p < .001).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.